Literature DB >> 28951374

[Rapid detection of alpha-globin gene αααanti-3.7 triplets with droplet digital PCR].

Xiao-Qian Gong1, Xue-Huang Yang, Lin-Li Qiao, Ya-Jun Cheng, Wan-Jun Zhou.   

Abstract

OBJECTIVE: To establish a rapid method for detection of alpha-globin gene αααanti-3.7 based on droplet digital PCR (ddPCR) technique.
METHODS: The differential sequence between the X1 and Y1 box of α1 gene was selected as the amplicon of the target gene with β-actin as the reference gene. The specific primers and TaqMan probes were designed, and then a quantitative method for detecting the copy number was established based on ddPCR technique. The sensitivity and accuracy of the method were evaluated by detecting 28 samples of known genotypes and 60 clinical samples.
RESULTS: The ddPCR-based method accurately identified the genotypes of all the 28 samples with known genotypes and detected 5 cases of αα/αααanti-3.7 from the 60 clinical samples, and the results were verified by MLPA. The sensitivity and accuracy of this method were both 100% for detecting alpha-globin gene αααanti-3.7.
CONCLUSION: This ddPCR-based method for detecting αααanti-3.7 triplet can be applied for population screening and in routine clinical molecular diagnosis with simple operation, rapid analysis and accurate results.

Entities:  

Year:  2017        PMID: 28951374      PMCID: PMC6765481     

Source DB:  PubMed          Journal:  Nan Fang Yi Ke Da Xue Xue Bao        ISSN: 1673-4254


  20 in total

1.  Evidence of Selection for the α-Globin Gene Deletions and Triplications in a Southern Chinese Population.

Authors:  Xing-Mei Xie; Man-Yu Wu; Dong-Zhi Li
Journal:  Hemoglobin       Date:  2015-08-19       Impact factor: 0.849

Review 2.  Thalassaemia screening and confirmation of carriers in parents.

Authors:  Angela N Barrett; Ramasamy Saminathan; Mahesh Choolani
Journal:  Best Pract Res Clin Obstet Gynaecol       Date:  2016-10-26       Impact factor: 5.237

3.  Rapid analysis of -alpha 3.7 thalassaemia and alpha alpha alpha anti 3.7 triplication by enzymatic amplification analysis.

Authors:  C Dodé; R Krishnamoorthy; J Lamb; J Rochette
Journal:  Br J Haematol       Date:  1993-01       Impact factor: 6.998

4.  Interaction of an α-Globin Gene Triplication with β-Globin Gene Mutations in Iranian Patients with β-Thalassemia Intermedia.

Authors:  Samaneh Farashi; Nooshin Bayat; Negin Faramarzi Garous; Mehri Ashki; Mona Montajabi Niat; Shadi Vakili; Hashem Imanian; Sirous Zeinali; Hossein Najmabadi; Azita Azarkeivan
Journal:  Hemoglobin       Date:  2015-06-18       Impact factor: 0.849

5.  The molecular basis of beta-thalassemia intermedia in southern China: genotypic heterogeneity and phenotypic diversity.

Authors:  Wanqun Chen; Xinhua Zhang; Xuan Shang; Ren Cai; Liyan Li; Tianhong Zhou; Manna Sun; Fu Xiong; Xiangmin Xu
Journal:  BMC Med Genet       Date:  2010-02-25       Impact factor: 2.103

6.  Frequency of alpha-globin gene triplications and their interaction with beta-thalassemia mutations.

Authors:  Piero C Giordano; Margaretha Bakker-Verwij; Cornelis L Harteveld
Journal:  Hemoglobin       Date:  2009       Impact factor: 0.849

Review 7.  Thalassemia 2016: Modern medicine battles an ancient disease.

Authors:  Deborah Rund
Journal:  Am J Hematol       Date:  2016-01       Impact factor: 10.047

8.  Combination of a triple alpha-globin gene with beta-thalassemia in a gypsy family: importance of the genetic testing in the diagnosis and search for a donor for bone marrow transplantation for one of their children.

Authors:  Flor Yus Cebrian; María del Valle Recasens Flores; Silvia Izquierdo Álvarez; Ingrid Parra Salinas; Carmen Rodriguez-Vigil Iturrate
Journal:  BMC Res Notes       Date:  2016-04-14

9.  Digital PCR, a technique for the future

Authors:  Valerie Taly; Jim Huggett
Journal:  Biomol Detect Quantif       Date:  2016-11-25

Review 10.  Thalassemia review: features, dental considerations and management.

Authors:  Nawal Helmi; Mawahib Bashir; Ayesha Shireen; Iffat Mirza Ahmed
Journal:  Electron Physician       Date:  2017-03-25
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.